Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ATHE Alterity Therapeutics
0.492
+0.002+0.41%
YOY
Do not show
Hide blank lines
(FY)2022/06/30(Q4)2022/06/30(Q2)2021/12/31(FY)2021/06/30
Assets
Current assets
Cash, cash equivalents and short term investments
23.8% 34.81M -- 34.81M 5.59% 37M 205.71% 28.12M
-Cash and cash equivalents
23.8% 34.81M -- 34.81M 5.59% 37M 205.71% 28.12M
Receivables
10.47% 4.73M -- 4.73M 216.6% 6.26M 6875.88% 4.28M
-Accrued interest receivable
-93.31% 18 -- 18 -94.9% 267 -97.86% 269
-Taxes receivable
10.47% 4.73M -- 4.73M 217.43% 6.26M 8676.51% 4.28M
Prepaid assets
47.43% 1.6M -- 1.6M -- -- 91.31% 1.09M
Other current assets
9.29% 10.23K -- 10.23K 358.85% 1.6M -8.68% 9.36K
Total current assets
22.86% 41.14M -- 41.14M 20.06% 44.86M 240.46% 33.49M
Non current assets
Net PPE
125.73% 218.52K -- 218.52K 78.68% 68.31K 35.64% 96.81K
-Gross PPE
-1.39% 733.06K -- 733.06K 78.68% 68.31K 15.57% 743.36K
-Accumulated depreciation
20.42% -514.54K -- -514.54K -- -- -13.07% -646.56K
Total non current assets
125.73% 218.52K -- 218.52K 78.68% 68.31K 35.64% 96.81K
Total assets
23.16% 41.36M -- 41.36M 20.12% 44.93M 238.99% 33.59M
Liabilities
Current liabilities
Payables
87.11% 2.77M -- 2.77M 34.8% 3.13M 53.62% 1.48M
-accounts payable
85.64% 2.69M -- 2.69M 34.8% 3.13M 51.83% 1.45M
-Total tax payable
-- 26.92K -- 26.92K -- -- -- --
-Other payable
70.25% 57.62K -- 57.62K -- -- 208.75% 33.85K
Current accrued expenses
131.33% 2.36M -- 2.36M -- -- -7.65% 1.02M
Current debt and capital lease obligation
107.71% 57.63K -- 57.63K -- 15.17K -15.61% 27.75K
-Current capital lease obligation
107.71% 57.63K -- 57.63K -- 15.17K -15.61% 27.75K
Other current liabilities
-- -26.92K -- -26.92K -- -- -- --
Current liabilities
89.74% 5.82M -- 5.82M 23.67% 3.76M 13.01% 3.07M
Non current liabilities
Long term debt and capital lease obligation
57.92% 59.86K -- 59.86K -- 26.73K 4266.71% 37.9K
-Long term capital lease obligation
57.92% 59.86K -- 59.86K -- 26.73K 4266.71% 37.9K
Employee benefits
40.8% 13.75K -- 13.75K 59.56% 12.91K -76.47% 9.77K
Total non current liabilities
54.41% 73.61K -- 73.61K 389.97% 39.63K 12.48% 47.67K
Total liabilities
89.2% 5.89M -- 5.89M 24.64% 3.8M 13% 3.12M
Shareholders'equity
Share capital
8.28% 213.79M -- 213.79M 9.71% 213.81M 22.86% 197.45M
-common stock
8.28% 213.79M -- 213.79M 9.71% 213.81M 22.86% 197.45M
Retained earnings
-7.16% -181.88M -- -181.88M -8.18% -176.31M -9.91% -169.73M
Gains losses not affecting retained earnings
29.63% 3.57M -- 3.57M 48.38% 3.63M 217.61% 2.75M
Total stockholders'equity
16.4% 35.47M -- 35.47M 19.71% 41.13M 326.11% 30.47M
Total equity
16.4% 35.47M -- 35.47M 19.71% 41.13M 326.11% 30.47M
Currency Unit
AUDAUDAUDAUD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion----Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Alterity Therapeutics Ltd. engages in the research and development into Parkinsonian and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
CEO: Dr. David A. Stamler,M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...